HB
This company develops proprietary bacteriophage formulations to combat specific bacterial pathogens in aquaculture. Their solution precisely targets harmful bacteria, such as those causing AHPND in shrimp, offering an alternative to traditional antibiotics. This approach supports sustainable aquaculture by safeguarding shrimp health while preserving environmental balance.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- PhagePro develops bacteriophage-based therapies to combat bacterial infections, offering a targeted approach to disease control. Their platform provides highly selective agents that infect and destroy specific bacteria, paving the way for new antibacterial treatments.